First Time Loading...

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 5.4 USD 3.85%
Updated: May 15, 2024

Aurinia Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
ZYME
TH
RPTX
FUSN
EDT

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Pre-Tax Income
-$61.7m
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-19%
Zymeworks Inc
NYSE:ZYME
Pre-Tax Income
-$119.2m
CAGR 3-Years
13%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Pre-Tax Income
-$17.6m
CAGR 3-Years
10%
CAGR 5-Years
-28%
CAGR 10-Years
-7%
Repare Therapeutics Inc
NASDAQ:RPTX
Pre-Tax Income
-$103.2m
CAGR 3-Years
-24%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Pre-Tax Income
-$94.1m
CAGR 3-Years
-8%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Pre-Tax Income
-CA$15.5m
CAGR 3-Years
-19%
CAGR 5-Years
-44%
CAGR 10-Years
-3%

See Also

What is Aurinia Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-61.7m USD

Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Pre-Tax Income amounts to -61.7m USD.

What is Aurinia Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-19%

Over the last year, the Pre-Tax Income growth was 35%. The average annual Pre-Tax Income growth rates for Aurinia Pharmaceuticals Inc have been 21% over the past three years , and -19% over the past ten years .